Change theme to redChange theme to blueChange theme to greenChoose your color
Last Modified Date: 17 Jan 2013
  • |
  • Printer Friendly
  • |
  • Download Adobe Reader
  • |
  • Small Font
  • Medium Font
  • Large Font
 

Technologies Available for Licensing

For Licensing Opportunities, please contact the ORTA at USAMRMCORTA@amedd.army.mil



EXTRANEOUS DNA SEQUENCE THAT FACILITATES HANTAVIRUS GENE EXPRESSION

In this application is described a protective DNA vaccines against infection with HFRS- and HPS-associated hantaviruses. The vaccines were constructed by subcloning cDNA representing the medium (M) (encoding the G1 and G2 glycoproteins) into the DNA expression vector pWRG7077. Animals vaccinated with the M construct developed a neutralizing antibody response. Passive transfer experiments show that serum from vaccinated animals, when injected on days 4 or 5 after challenge, protected animals from lethal disease.

Number:7,217,812

Date:2007-05-15

Type: Issued

Category: Vaccine

More Detail:Visit USPTO.GOVExternal link

Lab:WRAIR

Inventor(s):HOOPER, J.; SCHMALJOHN, C.; CUSTER, M.


For Licensing Opportunities, please contact the ORTA at USAMRMCORTA@amedd.army.mil
 

iSalute

This Web site provides an introduction to the Office of Research and Technology Applications (ORTA) and contains official Government information.

Its use is intended for members of the general public, news media and Military Health System beneficiaries.

Please address questions or concerns about this Web site to the USAMRMC Public Affairs Office at:
usamrmcwebmaster@amedd.army.mil or by telephone at (301)619-2736